TREATMENT OF MULTIPLE-MYELOMA RESISTANT TO INDUCTION THERAPY OR IN RELAPSE USING THE BAP PROTOCOL (BCNU, ADRIAMYCIN, PREDNISONE)

被引：0
|
作者：
TRIBALTO, M
FRANCHI, A
MARTELLI, M
LEONI, P
GUARINO, S
VACCA, A
PILERI, A
FRANCESCONI, M
CANTONETTI, M
TONATO, M
DANIELI, G
DERIU, L
DAMMACCO, F
MANDELLI, F
机构：
来源：
CHEMIOTERAPIA | 1983年 / 2卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：376 / 379
页数：4
相关论文
共 50 条
  • [31] DRUG-THERAPY - THE TREATMENT OF MULTIPLE-MYELOMA
    ALEXANIAN, R
    DIMOPOULOS, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (07): : 484 - 489
  • [32] COMPARISON OF ORAL MELPHALAN, CCNU, AND BCNU WITH AND WITHOUT VINCRISTINE AND PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA - CANCER-AND-LEUKEMIA-GROUP-B EXPERIENCE
    CORNWELL, GG
    PAJAK, TF
    KOCHWA, S
    MCINTYRE, OR
    GLOWIENKA, LP
    BRUNNER, K
    RAFLA, S
    SILVER, RT
    COOPER, MR
    HENDERSON, E
    KYLE, RA
    HAURANI, FI
    CUTTNER, J
    [J]. CANCER, 1982, 50 (09) : 1669 - 1675
  • [33] MELPHALAN-RESISTANT MULTIPLE-MYELOMA - RESULTS OF TREATMENT ACCORDING TO THE M-2 PROTOCOL
    STEINKE, B
    BUSCH, FW
    BECHERER, C
    OSTENDORF, P
    WALLER, HD
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (03) : 279 - 281
  • [34] CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE AND VINDESINE COMBINATION CHEMOTHERAPY IN MELPHALAN-RESISTANT MULTIPLE-MYELOMA
    VANDOBBENBURGH, OA
    HOUWEN, B
    PIERSMA, H
    MARRINK, J
    OCKHUIZEN, T
    HALIE, MR
    NIEWEG, HO
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1984, 27 (02): : 25 - 30
  • [35] ADRIAMYCIN, 1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA (BCNU, NSC-409962), CYCLOPHOSPHAMIDE PLUS PREDNISONE (ABC-P) IN MELPHALAN-RESISTANT MULTIPLE-MYELOMA
    PRESANT, CA
    KLAHR, C
    [J]. CANCER, 1978, 42 (03) : 1222 - 1227
  • [36] INTENSIVE SEQUENTIAL THERAPY FOR VAD-RESISTANT MULTIPLE-MYELOMA
    DIMOPOULOS, MA
    WEBER, DM
    HESTER, J
    DELASALLE, K
    CHAMPLIN, R
    ALEXANIAN, R
    [J]. LEUKEMIA & LYMPHOMA, 1994, 13 (5-6) : 479 - 484
  • [37] TREATMENT OF REFRACTORY MULTIPLE-MYELOMA WITH THE VINCRISTINE-ADRIAMYCIN-DEXAMETHASONE (VAD) REGIMEN
    STENZINGER, W
    BLOMKER, A
    HIDDEMANN, W
    VANDELOO, J
    [J]. BLUT, 1990, 61 (2-3): : 55 - 59
  • [38] INITIAL TREATMENT IN MULTIPLE-MYELOMA - NO ADVANTAGE OF MULTIDRUG CHEMOTHERAPY OVER MELPHALAN - PREDNISONE
    HJORTH, M
    HELLQUIST, L
    HOLMBERG, E
    MAGNUSSON, B
    RODJER, S
    WESTIN, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (02) : 185 - 191
  • [39] BOLUS THERAPY WITH MITOXANTRONE AND VINCRISTINE IN COMBINATION WITH HIGH-DOSE PREDNISONE (NOP-BOLUS) IN RESISTANT MULTIPLE-MYELOMA
    WISLOFF, F
    GIMSING, P
    HEDENUS, M
    HIPPE, E
    PALVA, I
    TALSTAD, I
    TURESSON, I
    WESTIN, J
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 48 (02) : 70 - 74
  • [40] TREATMENT OF EVOLVED MULTIPLE-MYELOMA USING STRONG DOSES OF ADRIAMYCIN, VINCRISTINE AND CONTINUOUS PERFUSION OF DEXAMETHASONE (VAD)
    MONCONDUIT, M
    GROSBOIS, B
    LELOET, X
    BERNARD, JF
    MICHAUX, JL
    JOUET, JP
    LAPORTE, JP
    TILLY, H
    NAJMAN, A
    PIGUET, H
    DESHAYES, P
    [J]. NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1985, 27 (02): : 90 - 90
12345